Over five million patients will soon be able to access Wi-Fi in early adopter GP practices as the NHS takes
Breaking News
- Brexit – Implications For the Pharma Industry in Ireland The UK’s referendum decision to leave the EU in May 2016 undoubtedly sent shockwaves throughout Europe. European countries are still struggling to interpret what ‘Brexit’ will mean for them. Ireland,...
- EMA to Work With Stakeholders to Improve Product Information For EU Medicines The European Medicines Agency (EMA) has published an action plan to improve the product information (PI) for EU medicines, an information package for patients and healthcare professionals that accompanies every single medicine authorised in...
- Diaceutics Wins at Export Industry Awards Diaceutics, the Irish data insights and solutions company helping patients receive potentially lifesaving medicine through better testing, won the Small & Emerging Exporter of the Year Award at the recent Export...
- Brexit – Key Issues For the Pharmaceutical Industry Brexit – the stark reality is that the UK’s EU membership and the application of all EU legislation in the UK ends automatically at midnight on 30th March 2019! Current understanding...
- European Commission Diagnoses the State of Health in the EU Only by rethinking our health systems can we ensure that they remain fit-for-purpose and provide patient-centred care. This is what the 28 Country Health Profiles recently published by the Commission,...
The University of Liverpool, in partnership with AKL Research and Development, will lead a clinical trial testing the potential of
Biopharmaceutical, analytical and bioanalytical contract solutions provider, SGS has announced that it is expanding its elemental analysis and testing capabilities
Basel-based BioMedPartners announes the first round of BioMedInvest III, its third equity venture capital fund at CHF75m. Up to 16
Healthcare communications specialists Fiona Edwards and Katie Langdon have launched a new creative agency specialising in pharmaceutical marketing services. Based
Global supply partner for drugs, biologics and consumer health products, Catalent, has announced that it has completed the acquisition of
Originally projected to be on the market by 2020, excitement about the contact lens to measure glucose levels from Novartis and Google
Merck & Co has terminated a Phase II/III trial testing its investigational medicine verubecestat in patients with mild to moderate
A new biologic agent – the most potent of its kind so far – is showing early promise as part
Botox maker Allergan said it would buy body-contouring product maker Zeltiq Aesthetics for about $2.48 billion (€2.34 billion), adding muscle
Johnson & Johnson is counting on new buy Actelion’s pulmonary arterial hypertension (PAH) meds to provide a top-line boost once
By hijacking a cancer cell’s own metabolism, researchers have found a way to tag and target elusive cancers with small-molecule
The Irish Government risks losing out on hundreds of millions of euro in savings on its drug bill because of
Multiple pharmaceutical companies have signed on to participate in a £14-million (approximately $17.47-million) research project focused on drug safety, according
On Feb. 2, 2017 Pharmapack Europe announced the winners of the 2017 Pharmapack Awards. The winners were revealed during the
Biotech company Nemaura Pharma has secured up to £5 million funding from private investors for the development of a hormone
A high-tech robot that helps surgeons perform highly precise and minimally-invasive surgery has been used over 1,000 times at Sheffield
One of Europe’s largest collaborative academic-industry research projects, designed to develop and assess novel approaches for identification of new markers
The European Commission (EC) has granted marketing authorisation in Europe for Sanofi‘s Suliqua, a titratable fixed-ratio combination of basal insulin
Advertisements
